p53 mutation, but not p53 overexpression, correlates with survival in head and neck squamous cell carcinoma
about
Molecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma.Molecular changes in the multistage pathogenesis of head and neck cancerPrognostic value of p53 mutations, bax, and spontaneous apoptosis in maxillary sinus squamous cell carcinoma.Serum prognostic biomarkers in head and neck cancer patients.The UMD-p53 database: new mutations and analysis tools.TP53 mutations in workers exposed to occupational carcinogens.Molecular markers in clinical radiation oncology.DNA ploidy may be a prognostic marker in stage I and II serous adenocarcinoma of the endometriumStatus of p53 and p27(KIP1) in Iranian Patients With Oral Squamous Cell Carcinoma.Mutant p53 proteins: between loss and gain of function.Molecular techniques and genetic alterations in head and neck cancer.EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancerPrognostic value of p53 for colorectal cancer after surgical resection of pulmonary metastases.An overview of the molecular pathology of head and neck cancer, and its clinical implications.Oncoapoptotic markers in oral cancer: prognostics and therapeutic perspective.Influence of epidermal growth factor receptor (EGFR), p53 and intrinsic MAP kinase pathway status of tumour cells on the antiproliferative effect of ZD1839 ("Iressa")Discordance of genetic alterations between primary head and neck tumors and corresponding metastases associated with mutational status of the TP53 gene.Strong expression of survivin is associated with positive response to radiotherapy and improved overall survival in head and neck squamous cell carcinoma patients.Role of p53 mutations, protein function and DNA damage for the radiosensitivity of human tumour cells.Combined expression of p53, cyclin D1 and epidermal growth factor receptor improves estimation of prognosis in curatively resected oral cancer.Head and neck tumor sites differ in prevalence and spectrum of p53 alterations but these have limited prognostic value.p53 mutation and cyclin D1 amplification correlate with cisplatin sensitivity in xenografted human squamous cell carcinomas from head and neck.Loss of p21 expression is associated with p53 mutations and increased cell proliferation and p27 expression is associated with apoptosis in maxillary sinus squamous cell carcinomaConstitutive activation and overexpression of NF-κB/c-Rel in conjunction with p50 contribute to aggressive tongue tumorigenesis
P2860
Q27824854-F85EC005-9E85-4F9B-8EA3-83E6FB5FB1F3Q28728638-49FB610C-71CA-4BEB-AB68-CADE14D28275Q30700915-ED481437-9666-4DCF-BBC4-F627C2815BB9Q34032646-15E122C7-03EA-4750-84D8-98E0CA789FA3Q35078713-399AB593-75B7-4F30-BA45-59782AC756BFQ35078737-FE014CA0-0EBC-4278-B6F2-42B772950A40Q35208840-68A91BD3-30D8-41B0-BB9A-870129B02CD2Q36203480-49F5126C-B022-4890-9DCE-875F6E1FB670Q36266721-04C3FB96-A53E-4E8E-8E29-11FC3284C89AQ36661775-9C62BF4A-BC06-454C-80D8-0AF3C07CC55CQ37233399-F494C9F3-F40B-4501-B632-F0C0048BB7ECQ37348956-BB24CB6D-B3D9-4848-BFAC-C9C259432164Q37526572-96EC0F86-BD49-4683-88DD-9C952D66EC39Q37903910-3D57A286-6D60-471D-9AD7-1C99969B23ADQ38212609-4C79B8CB-B312-48E9-BE61-7CFCD4320EF9Q38283276-F82C1A06-6529-455F-A916-4647B226A918Q39122496-D5598C1B-65EE-4824-847B-1B9FD4A8D927Q39169780-BB92D444-8B78-4245-A93F-00DFEBA98348Q40592811-114305A1-C605-4327-BB4C-4721B4E86330Q43993217-B09207AD-883C-4A16-9920-6BFB4601BDA3Q47236546-09CC721A-0BFB-49A5-A942-1E3E4997DADEQ51942880-D98A2E70-2878-4B5F-B43C-5949308E363AQ58080824-E41BCF8A-24EA-4E74-A341-1E983E008107Q58779438-0891E48F-599C-4FFF-A135-712865103F47
P2860
p53 mutation, but not p53 overexpression, correlates with survival in head and neck squamous cell carcinoma
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
p53 mutation, but not p53 over ...... d neck squamous cell carcinoma
@ast
p53 mutation, but not p53 over ...... d neck squamous cell carcinoma
@en
type
label
p53 mutation, but not p53 over ...... d neck squamous cell carcinoma
@ast
p53 mutation, but not p53 over ...... d neck squamous cell carcinoma
@en
prefLabel
p53 mutation, but not p53 over ...... d neck squamous cell carcinoma
@ast
p53 mutation, but not p53 over ...... d neck squamous cell carcinoma
@en
P2093
P2860
P356
P1476
p53 mutation, but not p53 over ...... d neck squamous cell carcinoma
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1998.632
P407
P577
1998-10-01T00:00:00Z